129 related articles for article (PubMed ID: 12599094)
1. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
Ali MM; Baraka OZ; AbdelRahman SI; Sulaiman SM; Williams JF; Homeida MM; Mackenzie CD
J Infect Dis; 2003 Feb; 187(4):714-7. PubMed ID: 12599094
[TBL] [Abstract][Full Text] [Related]
2. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
3. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda).
Korten S; Wildenburg G; Darge K; Büttner DW
Acta Trop; 1998 Jun; 70(2):217-31. PubMed ID: 9698269
[TBL] [Abstract][Full Text] [Related]
4. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
5. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
6. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis in a teenager from Africa.
Leake JA; Pong AL; Scher CA; Newbury RO; Cunningham BB
Arch Dermatol; 2004 Sep; 140(9):1161-6. PubMed ID: 15381564
[No Abstract] [Full Text] [Related]
9. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
[TBL] [Abstract][Full Text] [Related]
10. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
[TBL] [Abstract][Full Text] [Related]
11. Recent updates on onchocerciasis: diagnosis and treatment.
Udall DN
Clin Infect Dis; 2007 Jan; 44(1):53-60. PubMed ID: 17143815
[TBL] [Abstract][Full Text] [Related]
12. Onchocerciasis presenting with lower extremity, hypopigmented macules.
Vernick W; Turner SE; Burov E; Telang GH
Cutis; 2000 May; 65(5):293-7. PubMed ID: 10826090
[TBL] [Abstract][Full Text] [Related]
13. [Molecular approaches to the control of onchocerciasis in Mexico].
Rodríguez-Pérez MA
Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
[TBL] [Abstract][Full Text] [Related]
14. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Darge K; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.
Rodríguez-Pérez MA; Danis-Lozano R; Rodríguez MH; Bradley JE
Trop Med Int Health; 1999 Feb; 4(2):98-104. PubMed ID: 10206263
[TBL] [Abstract][Full Text] [Related]
16. The effect of ivermectin treatment on the antibody response to antigens of Onchocerca volvulus.
Gillespie AJ; Lustigman S; Rivas-Alcala AR; Bradley JE
Trans R Soc Trop Med Hyg; 1994; 88(4):456-60. PubMed ID: 7570844
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
Timmann C; Abraha RS; Hamelmann C; Buttner DW; Lepping B; Marfo Y; Brattig N; Horstmann RD
Br J Dermatol; 2003 Oct; 149(4):782-7. PubMed ID: 14616370
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
Burnham G
Am J Trop Med Hyg; 1995 Mar; 52(3):270-6. PubMed ID: 7694970
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal studies of skin microfilaria and antibody conversion rates in children living in an endemic focus of onchocerciasis in Nigeria.
Ogunrinade AF; Awolola SO; Rotimi O; Chandrashekar R
J Trop Pediatr; 2000 Dec; 46(6):348-51. PubMed ID: 11191146
[TBL] [Abstract][Full Text] [Related]
20. Head nodding syndrome and river blindness: a parasitologic perspective.
Kaiser C; Pion S; Boussinesq M
Epilepsia; 2009 Oct; 50(10):2325-6. PubMed ID: 19785668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
